Addyi was 1st authorised from the FDA in August 2015 to deal with hypoactive sexual need dysfunction (HSDD) in premenopausal Women of all ages. That's just another way of saying it boosts sex travel (also known as libido) in women that have not achieved menopause. It had been the 1st these types